|
Showing the most relevant articles for your search:NASDAQ:FLKS | Date | Time | Source | Headline | Symbol | Company | | 03/06/2019 | 4:14PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 03/06/2019 | 7:27AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 03/06/2019 | 7:00AM | Business Wire | Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results | NASDAQ:FLKS | Flex Pharma, Inc. |
| 02/15/2019 | 4:30PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 02/14/2019 | 6:22AM | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 02/12/2019 | 3:50PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 02/05/2019 | 10:05AM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 01/17/2019 | 4:10PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 01/10/2019 | 9:50AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 01/09/2019 | 11:27AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 01/04/2019 | 9:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 01/04/2019 | 9:04AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 01/04/2019 | 7:00AM | Business Wire | Flex Pharma & Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Thera... | NASDAQ:FLKS | Flex Pharma, Inc. |
| 12/28/2018 | 6:19AM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 12/27/2018 | 11:57AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 12/21/2018 | 5:17PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 12/21/2018 | 5:07PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 12/06/2018 | 3:30AM | PR Newswire (US) | Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical Officer | NASDAQ:FLKS | Flex Pharma, Inc. |
| 12/06/2018 | 3:30AM | PR Newswire (US) | Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical Officer | NASDAQ:FLKS | Flex Pharma, Inc. |
| 11/28/2018 | 8:38AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 11/05/2018 | 4:25PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 11/05/2018 | 8:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 11/05/2018 | 7:00AM | Business Wire | Flex Pharma Reports Third Quarter 2018 Financial Results | NASDAQ:FLKS | Flex Pharma, Inc. |
| 10/26/2018 | 4:29PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 10/26/2018 | 4:22PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 10/18/2018 | 5:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 10/18/2018 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 10/01/2018 | 4:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 09/10/2018 | 11:38AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 08/15/2018 | 2:25PM | Business Wire | DEADLINE AUGUST 20: The Schall Law Firm Announces it is Investigating Claims Against Flex Pharma, Inc. & Encourages Investors... | NASDAQ:FLKS | Flex Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:FLKS |
|